Compugen (CGEN) EBITDA Margin (2009 - 2026)

Compugen (CGEN) reported EBITDA Margin of 414.38% for Q1 2026, up 4683.0% on a YoY basis from 8.66% in Q1 2025, and up 397.86% sequentially from 83.23% in Q4 2025.

Compugen (CGEN) EBITDA Margin (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 14 years of EBITDA Margin data on file, last reported at 414.38% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 4683.0% year-over-year to 414.38%; the trailing twelve-month figure through Mar 2026 stood at 43.97% (up 9830.0% YoY), and the FY2025 full-year result was 43.05%, up 9649.0% from the prior year.
  • EBITDA Margin grew to 414.38% in Q1 2026, from 83.23% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 414.38% in Q1 2026 to a low of 2006.28% in Q2 2025.
  • A 5-year average of 182.43% and a median of 26.24% in 2024 frame the typical range for EBITDA Margin.
  • Peak annual rise in EBITDA Margin reached 59194 bps in 2025, while the deepest fall reached 170196 bps in 2025.
  • Tracing CGEN's EBITDA Margin over 5 years: stood at 47.05% in 2022, then jumped by 214 bps to 53.75% in 2023, then tumbled by 1046 bps to 508.7% in 2024, then soared by 116 bps to 83.23% in 2025, then jumped by 398 bps to 414.38% in 2026.
  • Business Quant data shows CGEN's EBITDA Margin at 414.38% in Q1 2026, 83.23% in Q4 2025, and 417.4% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 414.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 414.38%
Dec 31, 2025 83.23%
Sep 30, 2025 -417.40%
Jun 30, 2025 -2,006.28%
Mar 31, 2025 367.56%
Dec 31, 2024 -508.70%
Sep 30, 2024 26.24%
Jun 30, 2024 -304.33%
Mar 31, 2024 331.85%
Dec 31, 2023 53.75%
Dec 31, 2022 -47.05%
Dec 31, 2020 -454.55%
Sep 30, 2018 -42.72%
Dec 31, 2016 -16,484.91%
Sep 30, 2016 -11,381.43%
Jun 30, 2016 -1,412.90%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -8.75%
Sep 30, 2015 -3,019.21%
Jun 30, 2015 -3,117.94%